RSS

Pfizer

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

8 Sep 2017 15:00 News

Pfizer’s treatment for adults with newly diagnosed acute myeloid leukaemia whose tumors express the CD33 antigen (CD33-positive AML), Mylotarg (gemtuzumab ozogamicin), has been approved by the US Food and Drug Administration (FDA). more

4 Sep 2017 12:33 News

The Alliance Foundation Trials (AFT) — in conjunction with Pfizer and six international cancer research groups — has launched a randomised open-label Phase III clinical study, PATINA, to evaluate a combination therapy for breast cancer. more

23 Aug 2017 12:01 News

The US Food and Drug Administration (FDA) has approved a targeted therapy, Besponsa (inotuzumab ozogamicin), for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). more

21 Aug 2017 14:00 News

Contract development and manufacturing organisation (CDMO), Avara Pharmaceutical Services, has acquired the Italian sterile manufacturing facility in an agreement with Pfizer. more

14 Aug 2017 13:42 News

Three healthtech start-ups have been selected by biopharmaceutical company Pfizer to help get their technologies adopted onto the NHS. more

7 Jul 2017 11:37 News

Pfizer has provided an update on its biologics licence application (BLA) for its proposed epoetin alfa biosimilar after receiving a complete response letter (CRL) from the US Food and Drug Administration (FDA). more

26 Jun 2017 15:09 News

Astellas Pharma and Pfizer have announced an amendment to the clinical research protocol for the Phase III PROSPER trial evaluating XTANDI (enzalutamide) in patients with non-metastatic (M0) castration-resistant prostate cancer (CRPC) more

12 Jun 2017 10:45 News

A device that allows women to self-administer a long-acting contraceptive has been reduced in price. The Sayana Press has reduced in price from $1 to $0.85 per dose. more

10 May 2017 11:04 News

Pfizer has launched a website and app to help fight antimicrobial resistance. more

9 May 2017 14:44 News

Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for routine use as a result of cost — to the NHS for free for up to five months until a final decision by NICE is made. more

9 May 2017 11:20 News

A collaboration agreement has been announced by Domain Therapeutics and Pfizer, which is aimed at assessing the impact of mutations on different signalling pathways engaged by GPCRs. more

26 Apr 2017 00:00 News

Pfizer, GEA and G-Con Manufacturing team up to produce a portable manufacturing facility for oral solid dosage forms. more

19 Jan 2017 11:40 News

Global healthcare company Novo Nordisk, alongside global pharmaceutical company Pfizer, are investing $9 million into the Swedish-based digital health company AMRA. more

18 Jan 2017 10:00 News

The UK’s Competition and Markets Authority (CMA) dishes the two firms a record fine of nearly £90 million for charging excessive prices to the NHS for an anti-epilepsy drug. more

7 Dec 2016 09:13 News

Non-profit organisation Doctors Without Borders/ Médecins Sans Frontières (MSF) has rejected pharma company, Pfizer’s offer to a donate a significant number of pneumonia vaccines (PCV) to aid the children they serve. more

11 Oct 2016 16:30 News

An upcoming merger agreement between Pfizer and Anacor, worth around $5.2bn, is set to boost the companies’ pipeline candidates in the atopic dermatitis space, according to GlobalData more

3 Jun 2016 09:50 News

Merck and Pfizer’s medication for renal cell carcinoma (RCC) is the most likely immunotherapy combination to first arrive in market, according to Global Data more

18 May 2016 16:21 News

Sanofi has filed for a pre-merger notification regarding its intention to acquire Medivation, suggesting an acquisition could be back on the cards more

13 May 2016 12:36 News

Innovation – it’s everywhere in the pharmaceutical sector. Sometimes it’s a small step but more often it's continued effort into drug development, delivery or research that leads to the constant stream of new products and formulations more

27 Apr 2016 09:06 News